Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 13061-13070 Newer>

The Motley Fool March 16, 2006 Steven Mallas	Princeton Report Card Shows Improvement Princeton Review controls its losses, but is it a stock for a long-term portfolio?
The Motley Fool March 16, 2006 Andy Cross	Glee at Gymboree in Q4: Fool by Numbers The children's clothing retailer released fiscal fourth-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool March 16, 2006 Chuck Saletta	Dueling Fools: Dell Bear Rebuttal Tight margins, premium valuations compared with the market, and a lousy position in the computing value chain make Dell a risky company to own right now.
The Motley Fool March 16, 2006 Rich Smith	Dueling Fools: Dell Bull Rebuttal Dell's so good, so efficient, and so well known that its reputation and brand name enable it to sell computers at higher prices than others can charge. Dell shareholders then reap the benefits of that pricing power.
The Motley Fool March 16, 2006 Chuck Saletta	Dueling Fools: Dell Bear Buying shares of Dell just does not compute. Lower cost competition, a commoditized business line, and shifting consumer demands make Dell a risky place for investing.
The Motley Fool March 16, 2006 Rich Smith	Dueling Fools: Dell Bull Dell is currently selling for 20 times trailing earnings and fewer than 17 times trailing free cash flow. Its profits are projected to grow 15% per annum over the next five years. Is that a bargain? No. But it is a good price.
The Motley Fool March 16, 2006 Andy Cross	Gymboree's Fun 2005: Fool by Numbers The retailer released full fiscal year 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool March 16, 2006 Seth Jayson	Play the Right Numbers Dividends aren't just boring cash payments. They're predictors of long-term, market-beating returns.
The Motley Fool March 16, 2006 Rich Duprey	Avian Flu Ruffling Feathers Roche Pharmaceuticals boosts anti-flu drug production to quiet calls for generics. While the situation bears watching for now, it's not necessarily something for investors to get their feathers ruffled about.
The Motley Fool March 16, 2006 Seth Jayson	PainCare Hurts A big restatement is not made any better by the fact that it's "noncash." Should that matter to investors? You bet.
<Older 13061-13070 Newer> Return to current articles.